文献速递肝病

多细胞肝类器官模型用于研究丙型肝炎病毒感染与非酒精性脂肪性肝病进展

A multicellular liver organoid model for investigating hepatitis C virus infection and nonalcoholic fatty liver disease progression.
PubMed 文献 · Hepatology · 2023-11-16

研究建立由同一人多能干细胞分化的肝类器官与巨噬细胞共培养的多细胞肝类器官模型,巨噬细胞转为库普弗样细胞。该模型中HCV感染通过上调宿主脂质生成导致类器官脂质蓄积,巨噬细胞共培养时更明显;长期脂肪酸处理上调HCV扩增并促进炎症和纤维化。三种已进入3期临床试验的NASH药物在该模型中的效果与临床结局一致。

要点

  • 建立含库普弗样细胞的多细胞肝类器官模型,可模拟HCV与NAFLD的相互作用。
  • HCV感染通过上调宿主脂质生成导致类器官脂质蓄积,巨噬细胞共培养时更明显。
  • 长期脂肪酸处理上调HCV扩增并促进炎症和纤维化。

核心结论

  • 作者提出由肝细胞、库普弗样细胞和肝星状细胞组成的多细胞肝类器官模型,重现宿主-病毒互作和细胞间相互作用,为研究HCV患者NAFLD进展提供生理相关系统。

研究设计与样本

  • 研究采用同一人多能干细胞分化的肝类器官与巨噬细胞共培养系统构建多细胞肝类器官模型。

主要发现

  • 共培养的巨噬细胞转向库普弗样细胞类型,即体内存在的肝驻留巨噬细胞。
  • 在该多细胞含库普弗样细胞的肝类器官模型中,HCV感染通过上调宿主脂质生成导致类器官脂质蓄积,巨噬细胞共培养时更明显。
  • 长期脂肪酸处理肝类器官上调HCV扩增并促进炎症和纤维化。
  • 在该含库普弗样细胞的肝类器官模型中,三种已进入3期临床试验的NASH药物的效果与临床结局一致。

局限性

  • 原文未报告局限性

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND AND AIMS: HCV infection can be successfully managed with antiviral therapies; however, progression to chronic liver disease states, including NAFLD, is common. There is currently no reliable in vitro model for investigating host-viral interactions underlying the link between HCV and NAFLD; although liver organoids (LOs) show promise, they currently lack nonparenchymal cells, which are key to modeling disease progression. APPROACH AND RESULTS: Here, we present a novel, multicellular LO model using a coculture system of macrophages and LOs differentiated from the same human pluripotent stem cells (PSCs). The cocultured macrophages shifted toward a Kupffer-like cell type, the liver-resident macrophages present in vivo , providing a suitable model for investigating NAFLD pathogenesis. With this multicellular Kupffer-like cell-containing LO model, we found that HCV infection led to lipid accumulation in LOs by upregulating host lipogenesis, which was more marked with macrophage coculture. Reciprocally, long-term treatment of LOs with fatty acids upregulated HCV amplification and promoted inflammation and fibrosis. Notably, in our Kupffer-like cell-containing LO model, the effects of 3 drugs for NASH that have reached phase 3 clinical trials exhibited consistent results with the clinical outcomes. CONCLUSIONS: Taken together, we introduced a multicellular LO model consisting of hepatocytes, Kupffer-like cells, and HSCs, which recapitulated host-virus intercommunication and intercellular interactions. With this novel model, we present a physiologically relevant system for the investigation of NAFLD progression in patients with HCV.

来源:Hepatology,查看原文。版权归原作者所有。

引用

  1. Lee J, Gil D, Park H, et al. A multicellular liver organoid model for investigating hepatitis C virus infection and nonalcoholic fatty liver disease progression. Hepatology. 2023. PMID: 37976400. doi:10.1097/HEP.0000000000000683

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。